Literature DB >> 17254966

Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.

Matthias Grimmler1, Yuefeng Wang, Thomas Mund, Zoran Cilensek, Eva-Maria Keidel, M Brett Waddell, Heidelinde Jäkel, Michael Kullmann, Richard W Kriwacki, Ludger Hengst.   

Abstract

p27Kip1 controls cell proliferation by binding to and regulating the activity of cyclin-dependent kinases (Cdks). Here we show that Cdk inhibition and p27 stability are regulated through direct phosphorylation by tyrosine kinases. A conserved tyrosine residue (Y88) in the Cdk-binding domain of p27 can be phosphorylated by the Src-family kinase Lyn and the oncogene product BCR-ABL. Y88 phosphorylation does not prevent p27 binding to cyclin A/Cdk2. Instead, it causes phosphorylated Y88 and the entire inhibitory 3(10)-helix of p27 to be ejected from the Cdk2 active site, thus restoring partial Cdk activity. Importantly, this allows Y88-phosphorylated p27 to be efficiently phosphorylated on threonine 187 by Cdk2 which in turn promotes its SCF-Skp2-dependent degradation. This direct link between transforming tyrosine kinases and p27 may provide an explanation for Cdk kinase activities observed in p27 complexes and for premature p27 elimination in cells that have been transformed by activated tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17254966     DOI: 10.1016/j.cell.2006.11.047

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  165 in total

Review 1.  Understanding protein non-folding.

Authors:  Vladimir N Uversky; A Keith Dunker
Journal:  Biochim Biophys Acta       Date:  2010-02-01

2.  Functional dissection of an intrinsically disordered protein: understanding the roles of different domains of Knr4 protein in protein-protein interactions.

Authors:  Adilia Dagkessamanskaia; Fabien Durand; Vladimir N Uversky; Matteo Binda; Frédéric Lopez; Karim El Azzouzi; Jean Marie Francois; Hélène Martin-Yken
Journal:  Protein Sci       Date:  2010-07       Impact factor: 6.725

3.  Electrostatically accelerated coupled binding and folding of intrinsically disordered proteins.

Authors:  Debabani Ganguly; Steve Otieno; Brett Waddell; Luigi Iconaru; Richard W Kriwacki; Jianhan Chen
Journal:  J Mol Biol       Date:  2012-06-19       Impact factor: 5.469

4.  Dynamics of the BH3-Only Protein Binding Interface of Bcl-xL.

Authors:  Xiaorong Liu; Alex Beugelsdijk; Jianhan Chen
Journal:  Biophys J       Date:  2015-09-01       Impact factor: 4.033

5.  Mechanism of cell cycle entry mediated by the intrinsically disordered protein p27(Kip1).

Authors:  Li Ou; M Brett Waddell; Richard W Kriwacki
Journal:  ACS Chem Biol       Date:  2012-02-03       Impact factor: 5.100

6.  Excitatory and Mitogenic Signaling in Cell Death, Blood-brain Barrier Breakdown, and BBB Repair after Intracerebral Hemorrhage.

Authors:  Da-Zhi Liu; Frank R Sharp
Journal:  Transl Stroke Res       Date:  2012-03-15       Impact factor: 6.829

Review 7.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

8.  P27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinases.

Authors:  Debora Bencivenga; Annunziata Tramontano; Alessia Borgia; Aide Negri; Ilaria Caldarelli; Adriana Oliva; Silverio Perrotta; Fulvio Della Ragione; Adriana Borriello
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.

Authors:  Sabine Paternot; Bianca Colleoni; Xavier Bisteau; Pierre P Roger
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  Protein cysteine sulfinic acid reductase (sulfiredoxin) as a regulator of cell proliferation and drug response.

Authors:  K Lei; D M Townsend; K D Tew
Journal:  Oncogene       Date:  2008-05-05       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.